Difficulty: Medium
Average Score: 81%
Practice
Which of the following drugs are used in patients who have acute and chronic pulmonary disorders exacerbated by large amounts of secretions?
Correct answer
A
Rationale
In the context of pharmacological treatments for pulmonary disorders exacerbated by large amounts of secretions, the correct answer is A) Mucolytics. Mucolytics are drugs that help in thinning and loosening mucus in the airways, making it easier for patients to clear secretions from their lungs. This can be particularly beneficial for individuals with acute and chronic pulmonary conditions where secretions are a major issue.
Option B) Glucocorticoids are used to reduce inflammation in conditions like asthma and COPD, but they do not directly address the issue of excessive secretions in the airways.
Option C) Beta adrenergic antagonists are primarily used to treat conditions like asthma by dilating the airways, but they do not specifically target mucus clearance.
Option D) Antihistamines are more commonly used for allergies and cold symptoms, and they do not have a direct effect on mucus secretions in the lungs.
Educationally, understanding the specific mechanisms of action of different drug classes is crucial for healthcare professionals to make informed decisions in treating patients with pulmonary disorders. Knowing which drugs target mucus clearance versus inflammation or airway constriction helps tailor treatment plans to individual patient needs, improving outcomes and quality of care.
Option B) Glucocorticoids are used to reduce inflammation in conditions like asthma and COPD, but they do not directly address the issue of excessive secretions in the airways.
Option C) Beta adrenergic antagonists are primarily used to treat conditions like asthma by dilating the airways, but they do not specifically target mucus clearance.
Option D) Antihistamines are more commonly used for allergies and cold symptoms, and they do not have a direct effect on mucus secretions in the lungs.
Educationally, understanding the specific mechanisms of action of different drug classes is crucial for healthcare professionals to make informed decisions in treating patients with pulmonary disorders. Knowing which drugs target mucus clearance versus inflammation or airway constriction helps tailor treatment plans to individual patient needs, improving outcomes and quality of care.